Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 In-vitro diagnostics industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product type trends
2.1.3 Test type trends
2.1.4 Application trends
2.1.5 End-user trends
2.1.6 Regional trends
Chapter 3 In-vitro Diagnostics Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of infectious and chronic diseases worldwide
3.2.1.2 Growing adoption and rising demand for personalized medicine
3.2.1.3 Increasing adoption of point-of-care testing in developing countries
3.2.1.4 Surging number of pathology labs and services equipped with advanced diagnostics machine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of diagnostic services
3.2.2.2 Unfavorable reimbursement scenario
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By test type
3.3.3 By application
3.3.4 By end-user
3.4 COVID-19 impact analysis
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Abbott Laboratories
4.1.2 Becton, Dickinson, and Company
4.1.3 Bio-Rad Laboratories
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 In-vitro Diagnostics Market, By Product Type
5.1 Key segment trends
5.2 Reagents & kits
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Instruments
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 In-vitro diagnostics Market, By Test Type
6.1 Key segment trends
6.2 Clinical chemistry
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Immunoassay/immunochemistry
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Molecular diagnostics
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Hematology
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Urinalysis
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Others
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 In-vitro Diagnostics Market, By Application
7.1 Key segment trends
7.2 Oncology
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Infectious diseases
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Diabetes
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Cardiology
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Nephrology
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.7 Autoimmune diseases
7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.8 Drug testing/pharmacogenomics
7.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.9 Others
7.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 In-vitro Diagnostics Market, By End-user
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Diagnostic laboratories
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Academic & research institutes
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 In-vitro diagnostics Market Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Switzerland
9.3.8 Sweden
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Thailand
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.5.6 Peru
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Kuwait
9.6.4 UAE
9.6.5 Turkey
9.6.6 Egypt
9.6.7 Israel
9.6.8 Qatar
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton, Dickinson, and Company
10.3 bioMerieux SA
10.4 Bio-Rad Laboratories
10.5 Danaher Corporation
10.6 DiaSorin
10.7 F. Hoffmann-La Roche AG
10.8 Ortho Clinical Diagnostics (QuidelOrtho)
10.9 Siemens Healthineers
10.10 Sysmex Corporation
10.11 Thermo Fisher Scientific Inc
10.12 Qiagen
